Starbucks Corporation’s stock has climbed to within 2.4% of its 52-week high, trading at $107.92 on Tuesday, as investors weigh signs of recovery against stretched valuation multiples.
The coffee chain’s shares have advanced 28.1% year-to-date, supported by two consecutive quarterly earnings beats. In the most recent quarter, reported on July 29, adjusted earnings per share reached $0.85, exceeding the $0.66 consensus estimate by 28.8%, and the stock rose 2.7% in after-hours trading. The prior quarter, reported April 28, delivered a 19.1% EPS beat with a $0.50 result versus a $0.42 estimate, lifting the share price 7.8%. Nineteen analysts have revised their earnings estimates upward in response.
Despite the positive momentum, Starbucks faces structural margin pressures. Gross margin has contracted from 27.4% to 23.0% over the past two years, while net margin has declined from 11.5% to 5.0%, reflecting elevated costs and operational challenges. The company is executing a $2 billion cost-savings initiative aimed at reversing these trends.
Valuation metrics remain elevated. The trailing 12-month price-to-earnings ratio stands at 62.0x, while the forward multiple is 41.2x. Enterprise value to EBITDA is 24.8x, and the dividend yield is 2.3%. A fair-value model from BMO places Starbucks at $92.70, indicating a 14.1% overvaluation relative to the current share price of $107.92.
Analyst targets reflect cautious optimism. BMO maintains a $120 price target set on January 30, 2026, implying 11.2% upside, while the consensus target is $112.10, suggesting 3.8% potential upside. The stock’s technical indicators show mixed signals: the daily relative strength index is at 59.2, suggesting a healthy but not overbought position, while the weekly StochRSI is at 100, indicating maximum overbought conditions. The MACD remains positive and expanding, supporting a strong buy signal across daily, weekly, and monthly timeframes.
Earnings expectations for Starbucks remain bifurcated. Consensus estimates for fiscal 2028 project EPS between $3.66 and $3.75, while BMO forecasts approximately $4.00. In contrast, fiscal 2025 EPS is projected at $1.63, a 54% decline from fiscal 2023’s $3.58, underscoring near-term earnings volatility. The next earnings report is scheduled for October 29, 2026, before market open.
The stock’s proximity to its 52-week high of $110.51 suggests limited near-term upside, with potential pullback risks as investors reassess valuation levels amid ongoing margin headwinds.
